SIM
PRTK

Spark Investment Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Spark Investment Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,100
Closed -$434K – 751
2015
Q1 		$434K Buy
+14,100
New +$405K 0.06% 403
2014
Q4 		– Sell
-1,342
Closed -$32K – 826
2014
Q3 		$32K Hold
1,342
– – ﹤0.01% 650
2014
Q2 		$32K Buy
1,342
+417
+45% +$13.6K ﹤0.01% 611
2014
Q1 		$34K Hold
925
– – 0.01% 657
2013
Q4 		$37K Buy
+925
New +$39.3K 0.01% 625

Other funds holding PRTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Spark Investment Management's PRTK Position: Q2 2015 in Review

Spark Investment Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2015, closing a stake of 14,100 shares — an estimated $434K sold.

Spark Investment Management first reported a position in PRTK in Q4 2013 and held it in 5 quarters. The position peaked at $434K in Q1 2015. 68 funds tracked by Wall St. Rank hold PRTK as of Q2 2015.

  • Spark Investment Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 14,100 Paratek Pharmaceuticals, Inc. shares in Q2 2015, an estimated $434K.
  • Spark Investment Management first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
  • Spark Investment Management's Paratek Pharmaceuticals, Inc. position peaked at $434K in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.